Clinical trials - Press Releases

Date	Title	Company
12-Sep-2023	HUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in China	HUTCHMED
08-Sep-2023	Novotech Publishes Nasopharyngeal Carcinoma Global Clinical Trial Landscape Report	Novotech
08-Sep-2023	MERCURY-3 trial data show Roclanda® – latanoprost/netarsudil fixed dose combination – demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension1	Santen
08-Sep-2023	Positive interim data from phase lla trial of FG001 in head & neck cancer presented as a case report at the World Molecular Imaging Congress in Prague	FluoGuide
08-Sep-2023	Neuroplast successfully completes patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury	Neuroplast
08-Sep-2023	Actimed Therapeutics announces FDA approval of its Investigational New Drug application for Phase 2b/3 IMPACT clinical trials of S-pindolol benzoate to treat cancer cachexia	Actimed Therapeutics
08-Sep-2023	Ariceum Therapeutics doses first patient with its first-in-class targeted radiopharmaceutical drug satoreotide in its Phase Ib study in small cell lung cancer	Ariceum Therapeutics
06-Sep-2023	Vitestro starts largest-scale clinical trial globally for its autonomous blood drawing device, with enrolment of first patients in A.D.O.P.T.	Vitestro
05-Sep-2023	BellaSeno Reports Positive One-Year Patient Follow-Up Data for Resorbable Breast and Pectus Excavatum Scaffolds	BellaSeno GmbH
04-Sep-2023	Oncorena’s First Patient Treated with ONC175 (orellanine) in clinial phase I/II trial in Patients with Metastatic Renal Cancer and Dialysis at Karolinska University Hospital in Stockholm, Sweden	Oncorena
01-Sep-2023	UCB presents new data at 35th International Epilepsy Congress (IEC) highlighting important advancements across Fintepla®▼(fenfluramine) oral solution and broader epilepsies portfolio	UCB
01-Sep-2023	IMed Consultancy releases guide to Market Entry looking at the EU, the UK and the USA	IMed Consultancy
01-Sep-2023	The UK’s most dangerous drugs, according to new study	Abbeycare Foundation
31-Aug-2023	Endoscopy Equipment Market: A Comprehensive Study of Key Players and Strategies	Markets and Markets
29-Aug-2023	FluoGuide completes patient enrollment and treatment in FG001 phase llb clinical trial in aggressive brain cancer	FluoGuide
29-Aug-2023	Lytix Biopharma announces completion of patient recruitment in the ATLAS-IT-05 trial	Lytix Biopharma
24-Aug-2023	Alloksys reports interim results of its clinical phase IIb trial with Alkaline Phosphatase therapy RESCAP® in critical care patients	Alloksys
22-Aug-2023	New Educational Initiative, Clinical Trials For All, to Drive More Understanding, Participation, and Diversity	Clinical Trials For All
16-Aug-2023	BDD secures £2M to fuel expansion in early phase clinical trials following record year	BDD
15-Aug-2023	Bios Health Group Enters the Market to Offer Investment-Driven and Clinical Development Optimization Strategies for Biotech and Life Science Companies	Bios Health Group